Nitric oxide and caspase 3 mediated cytokine inducedapoptosis in acute leukemia

Asian Pacific Journal of Allergy and Immunology

Volumn 29, Issue 1, 2011, Pages 102-111

  Siripin, Darin ^a   Fucharoen, Suthat ^a   Tanyong, Dalina I ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Apoptosis; Caspase; Cytokine; Leukemia; Nitricoxide

Indexed keywords

CASPASE 3; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HL 60; CELL STRAIN K 562; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE;

APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; ENZYME ACTIVATION; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; K562 CELLS; LEUKEMIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 79958266499     PISSN: 0125877X     EISSN: 22288694     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Roberto NM. Blood and bone marrow pathology: Diagnostic Cytopathology. 2005;33:54-55.
2. Robak T, Wierzbowska A. Current and emerging therapies for acutemyeloid leukemia. Clin Ther. 2009;31:2349-70.
3. Barrett AJ, Le BK. Immunotherapy prospects for acute myeloidleukaemia. Clin Exp Immunol. 2010;161:223-32.
4. Khawli LA, Hu P, Epstein AL. Cytokine, Chemokine, and Co-Stimulatory Fusion Proteins for the Immunotherapy of Solid Tumors. Handb Exp Pharmacol. 2008;181:291-328.
5. Rizza P, Moretti F, Belardelli F. Recent advances on theimmunomodulatory effects of IFN-alpha: implications for cancerimmunotherapy and autoimmunity. Autoimmunity. 2010;43:204-9.
6. Moschella F, Proietti E, Capone I, Belardelli F. Combination strategiesfor enhancing the efficacy of immunotherapy in cancer patients. Ann N YAcad Sci. 2010;1194:169-78.
7. Bracci L, Proietti E, Belardelli F. IFN and Novel Strategies ofCombination Therapy for Cancer. Ann N Y Acad Sci. 2007;1112: 256-68.
8. Varela N, Munoz-Pinedo C, Ruiz-Ruiz C, Robledo G, Pedroso M, Lopez-Rivas A. Interferon-gamma Sensitizes Human Myeloid Leukemia Cells toDeath Receptor-mediated Apoptosis by a Pleiotropic Mechanism. J BiolChem. 2001;276:17779-87.
9. Kimura M, Haisa M, Uetsuka H, Takaoka M, Ohkawa T, Kawashima R, et al. TNF combined with IFN-[alpha] accelerates NF-[kappa]B-mediatedapoptosis through enhancement of Fas expression in colon cancer cells. Cell Death Differ. 2003;10:718-28.
10. Elahi M, Asopa S, Matata B. NO-cGMP and TNF-alpha counterregulatory system in blood: understanding the mechanisms leading tomyocardial dysfunction and failure. Biochim Biophys Acta. 2007;1772:5-14.
11. Hatano E. Tumor necrosis factor signaling in hepatocyte apoptosis. J Gastroenterol Hepatol. 2007;22: 43-4.
12. Xu G, Zhang Y, Zhang L, Ren G, Shi Y. Bone marrow stromal cellsinduce apoptosis of lymphoma cells in the presence of IFNgamma andTNF by producing nitric oxide. Biochem Biophys Res Commun.2008;375:666-70.
13. Tian B, Liu J, Bitterman PB., Bache RJ. Mechanisms of cytokineinduced NO- mediated cardiac fibroblast apoptosis. Am J PhysiolHeart Circ Physiol.2002;283:1958-67.
14. Wakabayashi I, Nakano T, Takahashi Y. Enhancement of interleukin-1beta-induced iNOS expression in cultured vascular smooth muscle cellsof Goto-Kakizaki diabetes rats. Eur J Pharmacol. 2010;629:1-6.
15. Manz MG, Miyamoto T, Akashi K, Weissman I. Prospective isolation ofhuman clonogenic common myeloid progenitors. PNAS. 2002;99:11872-11877.
16. Wang X, Sun H., Li C. Nitric oxide induces promyelocytic cell growtharrest and apoptosis through deactivation of Akt pathway. Leuk Res.2007;31:653-60.
17. Bartkova J, Horejsí Z, Koed K, Kramer A, Tort F, Zieger K, et al. DNA damage response as a candidate anti-cancer barrier in early humantumorigenesis. Nature. 2005;14:864-70.
18. Debatin KM, Stahnke K, Fulda S. Apoptosis in hematological disorders.Semin Cancer Biol. 2003;13:149-58.
19. Saldeen J, Welsh N. p38 MAPK inhibits JNK2 and mediates cytokineactivated iNOS induction and apoptosis independently of NFκBtranslocation in insulin producing cells. Eur Cytokine Netw. 2004;15:47-52.
20. Grethe S, Ares MP, Andersson T, Porn-Ares MI. p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation anddownregulation of Bcl-xL. Exp Cell Res. 2004;298:632-42.
21. + cells. Exp Hematol. 2002;30:1238-47.
22. Li CQ, Wogan GN. Nitric oxide as a modulator of apoptosis. Cancer Letters. 2005; 226:1-15.
23. Fujiwara T, Fujita H, Okimura Y, Utsumi K. Immunoregulation andapoptosis induction of nitric oxide in the human mixed lymphocytesculture. Transplant Proc. 2006;38:3211-3.
24. Sagoo P, Chan G, Larkin DF, George AJ. Inflammatory Cytokines InduceApoptosis of Corneal Endothelium through Nitric Oxide. Invest Ophthalmol Vis Sci. 2004;45:3964-73.
25. Chan ED, Riches DW. IFN-{gamma} + LPS induction of iNOS ismodulated by ERK, JNK/SAPK, and p38mapk in a mouse macrophagecell line. Am J Physiol Cell Physiol. 2001;280:441-50.
26. Wan L, Cao D, Zeng J, Ziemba A, Pizzorno G. Activation of Stat1, IRF-1, and NF-kappaB is Required for the Induction of Uridine Phosphorylaseby Tumor Necrosis Factor-alpha and Interferon-gamma. Nucleosides Nucleotides Nucleic Acids. 2010; 29:488-503.
27. Brough D, Rothwell NJ. Caspase-1-dependent processing of prointerleukin-1β is cytosolic and precedes cell death. J Cell Sci.2007;120:772-81.
28. Hun Sik Kim, Myung-Shik Lee. Essential Role of STAT1 in Caspase-Independent Cell Death of Activated Macrophages through the p38 Mitogen-Activated Protein Kinase/STAT1/Reactive Oxygen Species Pathway. Mol Cell Biol. 2005;25:6821-33.
29. Voelkel-Johnson C, Thorne TE, Laster SM. Susceptibility to TNF in thepresence of inhibitors of transcription or translation is dependent on theactivity of cytosolic phospholipase A2 in human melanoma tumor cells. J Immunol. 1996;156:201-7.
30. Chen Q, Pattacini L, Boiardi L, Salvarani C. Tumor necrosis factor-alphaprotects synovial cells from nitric oxide induced apoptosis throughphosphoinositide 3-kinase Akt signal transduction. J Rheumatol.2006;33:1061-8.